CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL
CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL
Recruiting · NCT06304857 · Registry updated 2024-12-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, heart failure, neoplasm, skin disorder | Recruiting | Phase 3 | 2024-12-04 | NCT06304857 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| 4th Military Clinical Hospital with Polyclinic, Poland | 8 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| 4th Military Clinical Hospital with Polyclinic | Wroclaw | Poland | 2 |
| Lower Silesian Centre for Oncology, Lung Diseases and Hematology | Wroclaw | Poland | 1 |
| Military Medical Institute | Warsaw | Poland | 1 |